BamSEC and AlphaSense Join Forces
Learn More

Turn Therapeutics Inc. – Material Contracts

NASDAQ: TTRX    
Share price (7/1/26): $6.85    
Market cap (7/1/26): $204 million

Material Contracts Filter

EX-10.1
from 8-K 11 pages Certain Information in This Exhibit, Marked by [***], Has Been Excluded Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Material Supply and Development Agreement
12/34/56
EX-10.4
from 8-K 16 pages Executive Employment Agreement
12/34/56
EX-10.3
from 8-K 16 pages Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 31 pages Registration Rights Agreement by and Among Turn Therapeutics Inc. and the Stockholders Identified on the Signature Page Hereto Dated as of September 11, 2025
12/34/56
EX-10.1
from 8-K 8 pages Stockholders Agreement
12/34/56
EX-10.12
from S-1/A 3 pages Side Letter to Purchase Agreement September 24, 2025‎
12/34/56
EX-10.5
from S-1/A 22 pages Turn Therapeutics, Inc. 2025 Omnibus Incentive Plan
12/34/56
EX-10.4
from S-1/A 17 pages Executive Employment Agreement
12/34/56
EX-10.3
from S-1/A 16 pages Executive Employment Agreement
12/34/56
EX-10.11
from S-1 8 pages Stockholders Agreement
12/34/56
EX-10.10
from S-1 32 pages Form of Registration Rights Agreement by and Among Turn Therapeutics Inc. and the Stockholders Identified on the Signature Page Hereto Dated as of [●], 2025
12/34/56
EX-10.9
from S-1 19 pages Platform Intellectual Property License Agreement
12/34/56
EX-10.8
from S-1 12 pages Global Health Solutions, Inc. 2018 Stock Plan Notice of Stock Option Grant
12/34/56
EX-10.7
from S-1 13 pages Global Health Solutions, Inc. 2018 Stock Plan
12/34/56
EX-10.6
from S-1 23 pages Global Health Solutions, Inc. 2024 Equity Incentive Plan Global Health Solutions, Inc. 2024 Equity Incentive Plan
12/34/56
EX-10.5
from S-1 22 pages Turn Therapeutics, Inc. 2025 Omnibus Incentive Plan
12/34/56
EX-10.2
from S-1 21 pages Amended and Restated Registration Rights Agreement August 29, 2025
12/34/56
EX-10.1
from S-1 97 pages Amended and Restated Share Purchase Agreement Dated as of August 29, 2025 by and Among Global Health Solutions, Inc. (D/B/a Turn Therapeutics), Gem Global Yield LLC Scs and Gem Yield Bahamas Limited
12/34/56